These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23436807)

  • 41. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosa.
    Perez LR; Barth AL
    Braz J Infect Dis; 2011; 15(4):301-4. PubMed ID: 21860998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents.
    Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1997; 43(2):137-41. PubMed ID: 9084923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Artesunate against
    Bao L; Guo J; Feng L; Zhou X; Lu Q
    Biomed Res Int; 2019; 2019():4810217. PubMed ID: 31815139
    [No Abstract]   [Full Text] [Related]  

  • 47. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm.
    Banin E; Brady KM; Greenberg EP
    Appl Environ Microbiol; 2006 Mar; 72(3):2064-9. PubMed ID: 16517655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill
    Sweeney E; Sabnis A; Edwards AM; Harrison F
    Microbiology (Reading); 2020 Dec; 166(12):1171-1180. PubMed ID: 33253080
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
    Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
    Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.
    Alhede M; Kragh KN; Qvortrup K; Allesen-Holm M; van Gennip M; Christensen LD; Jensen PØ; Nielsen AK; Parsek M; Wozniak D; Molin S; Tolker-Nielsen T; Høiby N; Givskov M; Bjarnsholt T
    PLoS One; 2011; 6(11):e27943. PubMed ID: 22132176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung.
    Miller JK; Brantner JS; Clemons C; Kreider KL; Milsted A; Wilber P; Yun YH; Youngs WJ; Young G; Badawy HT; Milsted A; Clemons C; Kreider KL; Wilber P; Young G; Yun YH; Wagers PO; Youngs WJ
    Math Med Biol; 2014 Jun; 31(2):179-204. PubMed ID: 23518337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
    Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
    APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intragenic Antimicrobial Peptide Hs02 Hampers the Proliferation of Single- and Dual-Species Biofilms of
    Bessa LJ; Manickchand JR; Eaton P; Leite JRSA; Brand GD; Gameiro P
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340580
    [No Abstract]   [Full Text] [Related]  

  • 54. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    Soren O; Rineh A; Silva DG; Cai Y; Howlin RP; Allan RN; Feelisch M; Davies JC; Connett GJ; Faust SN; Kelso MJ; Webb JS
    J Antimicrob Chemother; 2020 Jan; 75(1):117-125. PubMed ID: 31682251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides.
    Chen H; Wubbolts RW; Haagsman HP; Veldhuizen EJA
    Sci Rep; 2018 Jul; 8(1):10446. PubMed ID: 29993029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silver oxynitrate - an efficacious compound for the prevention and eradication of dual-species biofilms.
    Lemire JA; Kalan L; Gugala N; Bradu A; Turner RJ
    Biofouling; 2017 Jul; 33(6):460-469. PubMed ID: 28521545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.
    Haney EF; Trimble MJ; Cheng JT; Vallé Q; Hancock REW
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29883434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
    Dales L; Ferris W; Vandemheen K; Aaron SD
    Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.